Securities code: Fujian Cosunter Pharmaceutical Co.Ltd(300436) securities abbreviation: Fujian Cosunter Pharmaceutical Co.Ltd(300436) Announcement No.: 2022047
Fujian Cosunter Pharmaceutical Co.Ltd(300436)
Suggestive announcement on the disclosure of the first quarter report of 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (hereinafter referred to as “the company”) held the 13th meeting of the 4th board of directors and the 12th meeting of the 4th board of supervisors on April 21, 2022, deliberated and adopted the company’s proposal on the first quarter report of 2022.
In order to enable investors to fully understand the company’s operating results and financial status in the first quarter of 2022, the company’s first quarter report of 2022 will be published on cninfo.com (www.cn. Info. Com. CN), the gem information disclosure website designated by China Securities Regulatory Commission, on April 22, 2022 Investors are kindly requested to pay attention to it.
It is hereby announced.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) board of directors April 21, 2022
